ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p630.xmlSoft Tissue Sarcoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p630.pdf2026-04-18Soft Tissue Sarcomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-pxxx.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-pxxx.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p625.xmlNCCN Guidelines and Their Impact on Coverage Policy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p625.pdf2026-04-18NCCN Guidelines and Their Impact on Coverage Policyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p677.xmlSpecific Targets in Sarcoma and Developmental Therapeutics2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p677.pdf2026-04-18Specific Targets in Sarcoma and Developmental Therapeuticshttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p731.xmlPelvic Bone Sarcomas: Controversies and Treatment Options2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p731.pdf2026-04-18Pelvic Bone Sarcomas: Controversies and Treatment Optionshttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p688.xmlBone Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p688.pdf2026-04-18Bone Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p715.xmlExperimental Therapies and Clinical Trials in Bone Sarcoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/6/article-p715.pdf2026-04-18Experimental Therapies and Clinical Trials in Bone Sarcoma